Navigation Links
Basil Zimmo Joins Finesse Solutions as Vice-President of Software
Date:5/6/2008

SANTA CLARA, Calif., May 6 /PRNewswire/ -- Finesse Solutions, LLC, Santa Clara, CA, a manufacturer of measurement and control solutions for life sciences process applications, announced the appointment of Basil Zimmo as its Vice-President of Software. Basil brings over 19 years of international program and senior management experience, with a focus on implementing high efficiency engineering, resource optimization, and global performance metrics. Basil was most recently a Senior Program Manager for handheld products at Research in Motion (RIM). Prior to joining RIM, Basil held senior management roles at Picarro Canada, Inc. and telecommunications companies such as Nortel Networks and JDS Uniphase, and has held positions at semiconductor chip companies such as AMD, Mitel Semiconductor, Phillips Semiconductor, GEC Plessey and Hughes Aircraft Company.

At Finesse Solutions, Mr. Zimmo will lead the new, Santa Clara-based software team in developing the TruBio bioreactor control platform. Mr. Zimmo said, "I am delighted to join Finesse, and work closely with both sensor and hardware teams to develop the next generation TruBio software. Finesse has a unique opportunity to innovate and address the evolving needs of bio-processing applications."

According to Finesse Solutions CEO Dr. Barbara Paldus, "We are delighted to embark on developing future versions of TruBio software based on state-of-the art programming platforms, that will future-proof our offering and add new capabilities for end users. We look forward to offering end users significantly improved code and novel, advanced features in the near future."

About Finesse Solutions, LLC

California-based Finesse Solutions, LLC, leads the way in developing new measurement and control technologies, in order to enable the transition to single-use systems, bring new capabilities to existing bioreactor platforms, and harmonize global bio-process information transfer. Our current product family provides comprehensive measurement and control solutions for upstream processes in the biotech and pharmaceutical industries. For more information, please visit us at http://www.finesse.com.


'/>"/>
SOURCE Finesse Solutions, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Drugs from Johnson & Johnson/Basilea and Forest Are the Most Promising Antibiotics in the Community-Acquired Pneumonia Pipeline
2. Trisha Dowling Joins Biomatrica as Vice President, Sales and Marketing
3. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
4. Harvey Morgan Joins CryoLife Board of Directors
5. Richard A. Schatz, M.D. Joins Cardiums Scientific Advisory Board
6. Dr. Arie S. Belldegrun, MD, FACS Joins Two River Group Holdings as Chairman and Partner
7. Robert W. Lee, Ph.D. Joins Particle Sciences as Vice President of Pharmaceutical Development
8. Dr. Elizabeth Brown Joins Argenta TEC
9. David S. Tierney, M.D., Joins Thomas, McNerney & Partners as Entrepreneur-In-Residence
10. Matthew J. Pfeffer Joins MannKind as Corporate Vice President and Chief Financial Officer
11. The Scripps Translational Science Institute Joins The MetaMiner Cardiac Consortium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... a leading provider of patient support solutions, has announced the ... which will launch this week. The VMS CNEs will address ... enhance the patient care experience by delivering peer-to-peer education programs ... to help women who have been diagnosed and are being ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Disappearing forests and increased emissions are the main ... people each year. Especially those living in larger cities are affected by air pollution ... of the most pollution-affected countries globally - decided to take action. , “I knew ...
(Date:10/11/2017)... Bay, Florida (PRWEB) , ... October 11, 2017 ... ... and Drug Administration (FDA) has granted orphan drug designation to SBT-100, its novel ... (sdAb) for the treatment of osteosarcoma. SBT-100 is able to cross the cell ...
(Date:10/10/2017)... , ... October 10, 2017 ... ... cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing ... HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s ...
Breaking Biology Technology:
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... Annual Report on Form 10-K on Thursday April 13, 2017 with ... ... Relations section of the Company,s website at http://www.nxt-id.com  under "SEC ... . 2016 Year Highlights: Acquisition ...
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market ... Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast ... from USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, ... ... MarketsandMarkets Logo ...
(Date:4/11/2017)... 2017 Research and Markets has announced the ... to their offering. ... eye tracking market to grow at a CAGR of 30.37% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
Breaking Biology News(10 mins):